If you are in recovery or thinking about addiction treatment and have seen stories about semaglutide or other GLP-1 medications, it’s natural to wonder whether they might help with cravings or relapse. This overview is designed for people living with a substance use disorder (SUD) who are exploring treatment options and want clear, honest information.
Here’s what we know.
Q: Are GLP-1 medications approved to treat addiction?
No.
GLP-1 medications are not FDA-approved for substance use disorder treatment. They are currently approved for conditions like diabetes and weight management.
Researchers are still studying how GLP-1 medications may effect the brain’s reward pathways, and some early, small studies suggest they might influence alcohol craving.
While GLP-1 medications are not considered a standard for medication-assisted therapy, there are FDA approved medications used to treat alcohol and opioid use disorders.
Q: Can GLP-1 medications be used off-label for addiction?
Sometimes, a medical provider may consider using a medication “off-label,” meaning for a purpose it is not formally approved for. If GLP-1 medications are being considered for substance use disorders, they should not replace evidence-based addiction care.
Q: Are GLP-1 medications safe during recovery?
Any decision about starting a GLP-1 medication in the context of addiction or recovery should be made with a medical professional who understands:
- Your substance use history
- Other medications you’re taking
- Your nutrition, weight history, and any other medical conditions
GLP-1 medications can have side effects such as:
- Reduced appetite and weight loss
- Nausea or digestive symptoms
- Hydration and nutritional instability
Q: What addiction treatments are proven to work?
Substance use disorder is a medical condition, and effective treatment begins with a comprehensive clinical evaluation, not just a prescription. Evidence-based care may include:
- A psychiatric evaluation to assess substance use patterns, mental health needs, and to determine appropriate medication options, including Medication-Assisted Treatment (MAT) such as:
- Naltrexone (oral or extended-release injectable)
- Acamprosate
- Buprenorphine
- Intensive Outpatient Programs (IOP), providing structured therapy multiple hours per week
- Individual and group therapy
- Treatment for co-occurring mental health conditions
These approaches have been extensively studied and are proven to reduce cravings, stabilize brain function, and lower the risk of relapse and overdose.
The Bottom Line
GLP-1 medications are a promising area of research, but they are not established treatments for addiction at this time. If you’re reading about semaglutide and addiction, you may be trying to:
- Better manage cravings
- Reduce risk of relapse
- Understand all your treatment options
At Forge Health, treatment begins with a comprehensive psychiatric evaluation and is built around evidence-based care — including MAT when appropriate — and structured outpatient programs such as IOP.
You deserve safe, proven treatment for your substance use disorder. To request a confidential evaluation, visit here: https://forgehealth.com/contact-us/.
Medically reviewed by Dr. Guy Maytal, Chief Medical Officer, Forge Health
Board Certified in Psychiatry
Last reviewed: March 2026
